You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Erythrpoietin Stimulating Agent (ESA)

Showing 1 - 25 of 8,001
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
  • +20 more
Dec 28, 2022

Anemia, Sickle Cell, Sickle Cell Disease Trial in Pittsburgh, Lagos (Hydroxyurea, Epoetin Alfa)

Not yet recruiting
  • Anemia, Sickle Cell
  • Sickle Cell Disease
  • Pittsburgh, Pennsylvania
  • +1 more
Aug 4, 2022

Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency Trial in United States (Ferric Citrate 1 gram Oral Tablet,

Completed
  • Hyperphosphatemia
  • +2 more
  • Ferric Citrate 1 gram Oral Tablet
  • Standard of care phosphate-lowering therapy
  • Anchorage, Alaska
  • +12 more
Nov 3, 2022

MDS, Anemia Trial in Germany (Luspatercept Injection)

Recruiting
  • Myelodysplastic Syndromes
  • Anemia
  • Luspatercept Injection
  • Berlin, Germany
  • +18 more
Jan 25, 2023

Chronic Kidney Disease Trial in Japan (roxadustat)

Completed
  • Chronic Kidney Disease
  • Aichi, Japan
  • +37 more
Apr 8, 2021

Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)

Recruiting
  • Anemia in Dialysis-dependent CKD Patients
  • Alexandria, Egypt
    Alexandria University
Oct 29, 2023

Anemia Associated With Chronic Kidney Disease (CKD) Trial in United States (Vadadustat, Mircera®)

Active, not recruiting
  • Anemia Associated With Chronic Kidney Disease (CKD)
  • Huntsville, Alabama
  • +57 more
Jan 31, 2022

MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Luspatercept
  • Epoetin Alfa
  • Concord, California
  • +100 more
Jul 20, 2023

Anemia Trial in Worldwide (Vadadustat, Darbepoetin alfa)

Completed
  • Anemia
  • Chula Vista, California
  • +58 more
Nov 10, 2022

MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

Recruiting
  • Myelodysplastic Syndromes
  • Canakinumab Injection
  • Darbepoetin Alfa
  • Tampa, Florida
    Moffitt Cancer Center
Nov 21, 2022

Anemia of Chronic Kidney Disease Trial in Hackensack (Vadadustat)

Suspended
  • Anemia of Chronic Kidney Disease
  • Hackensack, New Jersey
    Research Site
Aug 23, 2022

Anemia of Chronic Kidney Disease Trial in Hackensack (vadadustat)

Suspended
  • Anemia of Chronic Kidney Disease
  • Hackensack, New Jersey
    Research Site
Aug 23, 2022

Erythropoiesis Stimulating Agents for Anemia Management in

Completed
  • Anemia of Chronic Kidney Disease
  • +2 more
    • Giza, Egypt
      the Memorial Souad Kafafi University Hospital
    Jan 24, 2023

    MDS, MDS Trial in France (Luspatercept Injection [Reblozyl], Eprex)

    Recruiting
    • MDS
    • Myelodysplastic Syndromes
    • Luspatercept Injection [Reblozyl]
    • Eprex
    • Amiens, France
    • +30 more
    May 19, 2022

    End Stage Renal Disease on Dialysis Trial in Kaohsiung, (novel artificial intelligence assisted platform)

    Recruiting
    • End Stage Renal Disease on Dialysis
    • novel artificial intelligence assisted platform
    • Kaohsiung,, Taiwan
      Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
    Oct 5, 2021

    Anemia, End Stage Renal Disease Trial in London (Anemia Control Model (ACM), IV iron, Erythropoiesis-Stimulating Agent (ESA))

    Terminated
    • Anemia
    • End Stage Renal Disease
    • Anemia Control Model (ACM)
    • +2 more
    • London, United Kingdom
      Kings College Hospital
    Jan 6, 2020

    Hemodialysis Patients With Renal Anemia Trial in Japan (roxadustat)

    Completed
    • Hemodialysis Patients With Renal Anemia
    • Aichi, Japan
    • +24 more
    Dec 31, 2019

    ESA-naive Hemodialysis Chronic Kidney Disease Patients With Anemia Trial in Japan (roxadustat)

    Completed
    • ESA-naive Hemodialysis Chronic Kidney Disease Patients With Anemia
    • Aichi, Japan
    • +46 more
    Dec 31, 2019

    MDS Trial in Beijing (Roxadustat, Luspatercept)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
      Peking union medical college hospital
    Aug 17, 2023

    Kidney Failure, Chronic Trial in Seoul (Monofer (experimental), control group)

    Not yet recruiting
    • Kidney Failure, Chronic
    • Monofer (experimental)
    • control group
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Feb 5, 2023

    Anemia Trial in Anyang-si (Ferric Derisomaltose Injection, Darbepoetin Alfa Injection)

    Recruiting
    • Anemia
    • Ferric Derisomaltose Injection
    • Darbepoetin Alfa Injection
    • Anyang-si, Korea, Republic of
      Hallym University Medical Center
    Mar 13, 2023

    Renal Insufficiency, Chronic Trial in France (Reticera)

    Terminated
    • Renal Insufficiency, Chronic
    • Reticera
    • Angers, France
    • +8 more
    Mar 3, 2022

    MDS (MDS) Trial in United Kingdom (Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol)

    Recruiting
    • Myelodysplastic Syndromes (MDS)
    • Sodium Valproate, Bezafibrate, Medroxyprogesterone
    • Danazol
    • Dudley, England, United Kingdom
    • +7 more
    Aug 12, 2022

    Anaemia Trial in United States (Daprodustat, Epoetin alfa)

    Completed
    Has Results
    • Anaemia
    • La Mesa, California
    • +10 more
    Jun 2, 2021

    Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)

    Recruiting
    • Hematological Malignancy
    • Cancer-Related Anemia
    • Shengxuening Tablet
    • Ferrous succinate
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Mar 13, 2023